Cargill, K. R., Feder, N. M., Wilhite, T., Gellad, W. F., Skinner, H. D., Mowery, Y. M., & Wilke, C. T. (2026). Price transparency compliance and variation for proton therapy in the United States. Cancer Lett, 640, 218260. https://doi.org/10.1016/j.canlet.2026.218260

Cargill, Kasey R., Noah M. Feder, Tyler Wilhite, Walid F. Gellad, Heath D. Skinner, Yvonne M. Mowery, and Christopher T. Wilke. “Price transparency compliance and variation for proton therapy in the United States.” Cancer Lett 640 (March 1, 2026): 218260. https://doi.org/10.1016/j.canlet.2026.218260.

Cargill KR, Feder NM, Wilhite T, Gellad WF, Skinner HD, Mowery YM, et al. Price transparency compliance and variation for proton therapy in the United States. Cancer Lett. 2026 Mar 1;640:218260.

Cargill, Kasey R., et al. “Price transparency compliance and variation for proton therapy in the United States.” Cancer Lett, vol. 640, Mar. 2026, p. 218260. Pubmed, doi:10.1016/j.canlet.2026.218260.

Cargill KR, Feder NM, Wilhite T, Gellad WF, Skinner HD, Mowery YM, Wilke CT. Price transparency compliance and variation for proton therapy in the United States. Cancer Lett. 2026 Mar 1;640:218260.